The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s application to expand the indications for certain pacemakers and defibrillators for patients with heart failure. The ...
Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective. As described in a June notice made ...
The U.S. Food and Drug Administration issued its most serious type of recall for 348,616 Medtronic defibrillators, saying they are at risk for delivering "a reduced-energy shock or no shock at all," ...
Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...
MINNEAPOLIS -- Medtronic has issued a recall for over 348,000 defibrillators because there is a risk they deliver low shock, or no shock at all. The Class I recall - the most serious type of recall ...
Medtronic is recalling nearly 350,000 implantable cardiac devices due to continued problems with the delivery of high-voltage energy, according to an announcement from the US Food and Drug ...
Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...
TEL AVIV (MarketWatch) -- Medtronic Inc., the Minneapolis medical-technology company, said on Monday that it would voluntarily suspend distribution of the Sprint Fidelis family of defibrillation leads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results